Cambridge, United Kingdom

Richard John Davenport

This inventor holds 8 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Darwin Discovery Limited, Takeda Pharmaceutical Company Limited. Active years: 2001-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard John Davenport. Retrieved from https://idiyas.com/inventor/richard-john-davenport

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 12.5

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Cambridgeshire, GB (2018)
  • Cambridge, GB (2001 - 2019)

Company Filing History:


Years Active: 2001-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Richard John Davenport - Pioneering Pharmaceutical Research in Cambridge

Introduction:

Richard John Davenport, a distinguished inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceutical research. With a portfolio of 8 patents, his innovative work has reverberated throughout the industry, shaping new possibilities in drug discovery and development.

Latest Patents:

Among his latest patents are groundbreaking discoveries in the realm of pharmacology. Davenport's inventions include compounds and amide derivatives that hold immense potential for therapeutic applications. These novel structures and their pharmaceutical salts have opened new avenues for drug design and delivery, offering hope for improved treatments in various medical conditions.

Career Highlights:

Having showcased his expertise in the pharma sector, Richard John Davenport has left a lasting impact on companies such as Darwin Discovery Limited and Takeda Pharmaceutical Company Limited. His collaborative efforts and pioneering research have garnered acclaim within the industry, positioning him as a visionary in the realm of drug innovation.

Collaborations:

Throughout his career, Davenport has collaborated with esteemed professionals in the field, including Hazel Joan Dyke and Andrew Sharpe. Together, they have worked tirelessly to push the boundaries of pharmaceutical science, leading to the development of cutting-edge compounds and therapeutic solutions.

Conclusion:

In conclusion, Richard John Davenport stands as a beacon of innovation in the realm of pharmaceutical research. His relentless pursuit of excellence and unwavering commitment to scientific advancement continue to inspire and drive progress within the industry. With a rich tapestry of patents and collaborations shaping his legacy, Davenport's contributions to the field are nothing short of transformative.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…